Moreover, among the most significant signaling pathways related to DEGs in Rx‐Dicer mutants is the non‐alcoholic fatty liver disease pathway, headed by Irs2 (Fig 4F, Table EV8). The gene discussed is IRS2; the disease is fatty liver disease.